16:02 Dec 20
Supriya Lifescience Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Supriya Lifescience Ltd.
86/100 High Financial Strength
Quality31/100 Mid Valuation
Valuation67/100 Technically Moderately Bullish
TechnicalSWOT
Strength
10
Weakness
3
Opportunity
1
Threat
0
5.87K
Market Cap (Cr)
37.29
PE Ratio
6.48
Price to Book Ratio
49.58
RSI
0.00 %
Net Profit Margin
Rating Based on 2 Analysts
Buy
50%
Hold
50%
Sell
0%
Buy
Analyst Price Target
The average price target is 476.5 with a high estimate of 644 and low estimate of 644
Current 729.80
Disclaimer:The analysis information is for reference only and does not constitude an investment recommendation
SWOT
Download Our App On:
